Toremifene

Last Updated: 04/28/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 811 publications

Toremifene in desmoid fibromatosis: Prospective phase 2 study of two dose levels.

Toremifene in desmoid fibromatosis: Prospective phase 2 study of two dose levels.

Journal: European journal of cancer (Oxford, England : 1990)
Published: December 20, 2025

Topological insights into breast cancer drugs: a QSPR approach using resolving topological indices.

Topological insights into breast cancer drugs: a QSPR approach using resolving topological indices.

Journal: Frontiers in chemistry
Published: September 22, 2025

Case Report: Metachronous pancreatic adenocarcinoma following HER2-positive breast cancer and the implications of non-BRCA germline variants with TP53-mutant disease.

Case Report: Metachronous pancreatic adenocarcinoma following HER2-positive breast cancer and the implications of non-BRCA germline variants with TP53-mutant disease.

Journal: Frontiers in oncology
Published: September 14, 2025

Toremifene exerts chemopreventive effects against breast cancer through MTHFD1L suppression and ROS-mediated apoptosis.

Toremifene exerts chemopreventive effects against breast cancer through MTHFD1L suppression and ROS-mediated apoptosis.

Journal: Chinese medical journal
Published: August 15, 2025

Research progress of DUB enzyme in breast cancer.

Research progress of DUB enzyme in breast cancer.

Journal: Clinical and experimental medicine
Published: July 08, 2025

Treatment of ER-positive breast cancer with FDA-approved aromatase inhibitors.

Treatment of ER-positive breast cancer with FDA-approved aromatase inhibitors.

Journal: Cancer treatment and research communications
Published: May 26, 2025

A study to assess the vascular developmental toxicity of anticarcinogen toremifene in zebrafish (Danio rerio).

A study to assess the vascular developmental toxicity of anticarcinogen toremifene in zebrafish (Danio rerio).

Journal: Environmental science. Processes & impacts
Published: April 08, 2025

Editorial Expression of Concern: Nano-Targeted Delivery of Toremifene, an Estrogen Receptor-α Blocker in Prostate Cancer.

Editorial Expression of Concern: Nano-Targeted Delivery of Toremifene, an Estrogen Receptor-α Blocker in Prostate Cancer.

Journal: Pharmaceutical research
Published: March 15, 2025

Repurposing High-Throughput Screening Reveals Unconventional Drugs with Antimicrobial and Antibiofilm Potential Against Methicillin-Resistant Staphylococcus aureus from a Cystic Fibrosis Patient.

Repurposing High-Throughput Screening Reveals Unconventional Drugs with Antimicrobial and Antibiofilm Potential Against Methicillin-Resistant Staphylococcus aureus from a Cystic Fibrosis Patient.

Journal: Antibiotics (Basel, Switzerland)
Published: March 13, 2025

Treating ER-positive breast cancer: a review of the current FDA-approved SERMs and SERDs and their mechanisms of action.

Treating ER-positive breast cancer: a review of the current FDA-approved SERMs and SERDs and their mechanisms of action.

Journal: Oncology reviews
Published: January 21, 2025

Trends in Combinatorial Endocrine Therapy for Breast Cancer Across Six Cities in China(2016-2021).

Trends in Combinatorial Endocrine Therapy for Breast Cancer Across Six Cities in China(2016-2021).

Journal: Risk management and healthcare policy
Published: January 10, 2025

Targeted and cytotoxic inhibitors used in the treatment of breast cancer.

Targeted and cytotoxic inhibitors used in the treatment of breast cancer.

Journal: Pharmacological research
Published: November 28, 2024
Showing 1-12 of 811

Last Updated: 04/28/2026